nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP3A4—bone cancer	0.494	1	CbGaD
Propofol—CYP1B1—Doxorubicin—bone cancer	0.0734	0.373	CbGbCtD
Propofol—CYP2B6—Cisplatin—bone cancer	0.0366	0.186	CbGbCtD
Propofol—CYP2B6—Doxorubicin—bone cancer	0.0245	0.125	CbGbCtD
Propofol—ALB—Methotrexate—bone cancer	0.0233	0.119	CbGbCtD
Propofol—CYP2C9—Cisplatin—bone cancer	0.0193	0.0984	CbGbCtD
Propofol—CYP2D6—Doxorubicin—bone cancer	0.0119	0.0603	CbGbCtD
Propofol—CYP3A4—Doxorubicin—bone cancer	0.00754	0.0383	CbGbCtD
Propofol—Pancreatitis—Cisplatin—bone cancer	0.000763	0.00507	CcSEcCtD
Propofol—Musculoskeletal stiffness—Methotrexate—bone cancer	0.000758	0.00504	CcSEcCtD
Propofol—Sweating increased—Cisplatin—bone cancer	0.000758	0.00503	CcSEcCtD
Propofol—Delirium—Epirubicin—bone cancer	0.00074	0.00492	CcSEcCtD
Propofol—Oliguria—Methotrexate—bone cancer	0.000738	0.0049	CcSEcCtD
Propofol—Extravasation—Epirubicin—bone cancer	0.00073	0.00485	CcSEcCtD
Propofol—Stinging—Doxorubicin—bone cancer	0.000727	0.00483	CcSEcCtD
Propofol—Injection site pain—Doxorubicin—bone cancer	0.000722	0.00479	CcSEcCtD
Propofol—Ventricular extrasystoles—Epirubicin—bone cancer	0.000705	0.00468	CcSEcCtD
Propofol—Thinking abnormal—Epirubicin—bone cancer	0.000695	0.00462	CcSEcCtD
Propofol—Respiratory failure—Methotrexate—bone cancer	0.000693	0.0046	CcSEcCtD
Propofol—Oliguria—Epirubicin—bone cancer	0.000691	0.00459	CcSEcCtD
Propofol—Delirium—Doxorubicin—bone cancer	0.000685	0.00455	CcSEcCtD
Propofol—Acute coronary syndrome—Cisplatin—bone cancer	0.000684	0.00454	CcSEcCtD
Propofol—Renal failure—Cisplatin—bone cancer	0.000682	0.00453	CcSEcCtD
Propofol—Myocardial infarction—Cisplatin—bone cancer	0.00068	0.00452	CcSEcCtD
Propofol—Neuropathy peripheral—Cisplatin—bone cancer	0.00068	0.00452	CcSEcCtD
Propofol—Dyskinesia—Epirubicin—bone cancer	0.000677	0.0045	CcSEcCtD
Propofol—Extravasation—Doxorubicin—bone cancer	0.000675	0.00448	CcSEcCtD
Propofol—Creatinine increased—Epirubicin—bone cancer	0.000669	0.00444	CcSEcCtD
Propofol—Atrioventricular block—Epirubicin—bone cancer	0.000656	0.00436	CcSEcCtD
Propofol—Ventricular extrasystoles—Doxorubicin—bone cancer	0.000652	0.00433	CcSEcCtD
Propofol—Thinking abnormal—Doxorubicin—bone cancer	0.000643	0.00427	CcSEcCtD
Propofol—Oliguria—Doxorubicin—bone cancer	0.000639	0.00425	CcSEcCtD
Propofol—Hiccups—Epirubicin—bone cancer	0.000637	0.00423	CcSEcCtD
Propofol—Ventricular tachycardia—Epirubicin—bone cancer	0.000637	0.00423	CcSEcCtD
Propofol—Bradycardia—Cisplatin—bone cancer	0.000634	0.00421	CcSEcCtD
Propofol—Abnormal dreams—Epirubicin—bone cancer	0.000629	0.00418	CcSEcCtD
Propofol—Dyskinesia—Doxorubicin—bone cancer	0.000627	0.00416	CcSEcCtD
Propofol—Hyperkalaemia—Epirubicin—bone cancer	0.000626	0.00415	CcSEcCtD
Propofol—Creatinine increased—Doxorubicin—bone cancer	0.000619	0.00411	CcSEcCtD
Propofol—Salivary hypersecretion—Epirubicin—bone cancer	0.000618	0.00411	CcSEcCtD
Propofol—Atrioventricular block—Doxorubicin—bone cancer	0.000607	0.00403	CcSEcCtD
Propofol—Pulmonary oedema—Methotrexate—bone cancer	0.000606	0.00402	CcSEcCtD
Propofol—Blood urea increased—Epirubicin—bone cancer	0.000601	0.00399	CcSEcCtD
Propofol—Visual impairment—Cisplatin—bone cancer	0.0006	0.00399	CcSEcCtD
Propofol—Neuropathy—Epirubicin—bone cancer	0.000598	0.00397	CcSEcCtD
Propofol—Sepsis—Methotrexate—bone cancer	0.00059	0.00392	CcSEcCtD
Propofol—Ventricular tachycardia—Doxorubicin—bone cancer	0.000589	0.00391	CcSEcCtD
Propofol—Hiccups—Doxorubicin—bone cancer	0.000589	0.00391	CcSEcCtD
Propofol—Abnormal dreams—Doxorubicin—bone cancer	0.000582	0.00387	CcSEcCtD
Propofol—Tinnitus—Cisplatin—bone cancer	0.00058	0.00386	CcSEcCtD
Propofol—Hyperkalaemia—Doxorubicin—bone cancer	0.000579	0.00384	CcSEcCtD
Propofol—Flushing—Cisplatin—bone cancer	0.000578	0.00384	CcSEcCtD
Propofol—Salivary hypersecretion—Doxorubicin—bone cancer	0.000572	0.0038	CcSEcCtD
Propofol—Pulmonary oedema—Epirubicin—bone cancer	0.000567	0.00376	CcSEcCtD
Propofol—Hypertonia—Epirubicin—bone cancer	0.000558	0.00371	CcSEcCtD
Propofol—Arrhythmia—Cisplatin—bone cancer	0.000556	0.00369	CcSEcCtD
Propofol—Blood urea increased—Doxorubicin—bone cancer	0.000556	0.00369	CcSEcCtD
Propofol—Abnormal vision—Epirubicin—bone cancer	0.000555	0.00369	CcSEcCtD
Propofol—Neuropathy—Doxorubicin—bone cancer	0.000553	0.00367	CcSEcCtD
Propofol—Sepsis—Epirubicin—bone cancer	0.000552	0.00367	CcSEcCtD
Propofol—Mental disability—Epirubicin—bone cancer	0.000552	0.00367	CcSEcCtD
Propofol—Erythema—Cisplatin—bone cancer	0.000542	0.0036	CcSEcCtD
Propofol—Phlebitis—Epirubicin—bone cancer	0.000536	0.00356	CcSEcCtD
Propofol—Pulmonary oedema—Doxorubicin—bone cancer	0.000524	0.00348	CcSEcCtD
Propofol—Muscle spasms—Cisplatin—bone cancer	0.000521	0.00346	CcSEcCtD
Propofol—Hypertonia—Doxorubicin—bone cancer	0.000516	0.00343	CcSEcCtD
Propofol—Abnormal vision—Doxorubicin—bone cancer	0.000514	0.00341	CcSEcCtD
Propofol—Eye pain—Epirubicin—bone cancer	0.000512	0.0034	CcSEcCtD
Propofol—Sepsis—Doxorubicin—bone cancer	0.000511	0.0034	CcSEcCtD
Propofol—Mental disability—Doxorubicin—bone cancer	0.000511	0.0034	CcSEcCtD
Propofol—Anaphylactoid reaction—Methotrexate—bone cancer	0.00051	0.00339	CcSEcCtD
Propofol—Tremor—Cisplatin—bone cancer	0.000508	0.00337	CcSEcCtD
Propofol—Phlebitis—Doxorubicin—bone cancer	0.000496	0.0033	CcSEcCtD
Propofol—Anaphylactoid reaction—Epirubicin—bone cancer	0.000477	0.00317	CcSEcCtD
Propofol—Eye pain—Doxorubicin—bone cancer	0.000474	0.00315	CcSEcCtD
Propofol—Cardiac failure—Epirubicin—bone cancer	0.000474	0.00315	CcSEcCtD
Propofol—Convulsion—Cisplatin—bone cancer	0.00047	0.00312	CcSEcCtD
Propofol—Mood swings—Methotrexate—bone cancer	0.000468	0.00311	CcSEcCtD
Propofol—Pain in extremity—Epirubicin—bone cancer	0.000462	0.00307	CcSEcCtD
Propofol—Diplopia—Epirubicin—bone cancer	0.000462	0.00307	CcSEcCtD
Propofol—Myalgia—Cisplatin—bone cancer	0.000461	0.00306	CcSEcCtD
Propofol—Anxiety—Cisplatin—bone cancer	0.00046	0.00305	CcSEcCtD
Propofol—Affect lability—Epirubicin—bone cancer	0.000455	0.00302	CcSEcCtD
Propofol—Anaphylactic shock—Cisplatin—bone cancer	0.000442	0.00294	CcSEcCtD
Propofol—Oedema—Cisplatin—bone cancer	0.000442	0.00294	CcSEcCtD
Propofol—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000442	0.00293	CcSEcCtD
Propofol—Cardiac arrest—Epirubicin—bone cancer	0.000439	0.00292	CcSEcCtD
Propofol—Cardiac failure—Doxorubicin—bone cancer	0.000438	0.00291	CcSEcCtD
Propofol—Mood swings—Epirubicin—bone cancer	0.000438	0.00291	CcSEcCtD
Propofol—Blood creatinine increased—Epirubicin—bone cancer	0.000433	0.00288	CcSEcCtD
Propofol—Tachycardia—Cisplatin—bone cancer	0.000432	0.00287	CcSEcCtD
Propofol—Dehydration—Epirubicin—bone cancer	0.00043	0.00285	CcSEcCtD
Propofol—Diplopia—Doxorubicin—bone cancer	0.000428	0.00284	CcSEcCtD
Propofol—Pain in extremity—Doxorubicin—bone cancer	0.000428	0.00284	CcSEcCtD
Propofol—Hyperhidrosis—Cisplatin—bone cancer	0.000428	0.00284	CcSEcCtD
Propofol—Affect lability—Doxorubicin—bone cancer	0.000421	0.0028	CcSEcCtD
Propofol—Pancreatitis—Methotrexate—bone cancer	0.000418	0.00278	CcSEcCtD
Propofol—Hypotension—Cisplatin—bone cancer	0.000413	0.00275	CcSEcCtD
Propofol—Cardiac arrest—Doxorubicin—bone cancer	0.000407	0.0027	CcSEcCtD
Propofol—Mood swings—Doxorubicin—bone cancer	0.000405	0.00269	CcSEcCtD
Propofol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000403	0.00268	CcSEcCtD
Propofol—Blood creatinine increased—Doxorubicin—bone cancer	0.000401	0.00266	CcSEcCtD
Propofol—Dehydration—Doxorubicin—bone cancer	0.000398	0.00264	CcSEcCtD
Propofol—Paraesthesia—Cisplatin—bone cancer	0.000397	0.00264	CcSEcCtD
Propofol—Dyspnoea—Cisplatin—bone cancer	0.000394	0.00262	CcSEcCtD
Propofol—Pancreatitis—Epirubicin—bone cancer	0.000392	0.0026	CcSEcCtD
Propofol—Depression—Methotrexate—bone cancer	0.000379	0.00252	CcSEcCtD
Propofol—Pain—Cisplatin—bone cancer	0.000378	0.00251	CcSEcCtD
Propofol—Renal failure—Methotrexate—bone cancer	0.000374	0.00248	CcSEcCtD
Propofol—Feeling abnormal—Cisplatin—bone cancer	0.000364	0.00242	CcSEcCtD
Propofol—Pancreatitis—Doxorubicin—bone cancer	0.000362	0.00241	CcSEcCtD
Propofol—Hyperglycaemia—Epirubicin—bone cancer	0.00036	0.00239	CcSEcCtD
Propofol—Renal failure—Epirubicin—bone cancer	0.00035	0.00233	CcSEcCtD
Propofol—Body temperature increased—Cisplatin—bone cancer	0.00035	0.00232	CcSEcCtD
Propofol—Neuropathy peripheral—Epirubicin—bone cancer	0.000349	0.00232	CcSEcCtD
Propofol—Haemoglobin—Methotrexate—bone cancer	0.000343	0.00228	CcSEcCtD
Propofol—Haemorrhage—Methotrexate—bone cancer	0.000342	0.00227	CcSEcCtD
Propofol—Pharyngitis—Methotrexate—bone cancer	0.000339	0.00225	CcSEcCtD
Propofol—Hyperglycaemia—Doxorubicin—bone cancer	0.000333	0.00221	CcSEcCtD
Propofol—Visual impairment—Methotrexate—bone cancer	0.000329	0.00219	CcSEcCtD
Propofol—Bradycardia—Epirubicin—bone cancer	0.000325	0.00216	CcSEcCtD
Propofol—Renal failure—Doxorubicin—bone cancer	0.000324	0.00215	CcSEcCtD
Propofol—Neuropathy peripheral—Doxorubicin—bone cancer	0.000323	0.00215	CcSEcCtD
Propofol—Haemoglobin—Epirubicin—bone cancer	0.000321	0.00213	CcSEcCtD
Propofol—Haemorrhage—Epirubicin—bone cancer	0.00032	0.00212	CcSEcCtD
Propofol—Tinnitus—Methotrexate—bone cancer	0.000319	0.00212	CcSEcCtD
Propofol—Asthenia—Cisplatin—bone cancer	0.000317	0.00211	CcSEcCtD
Propofol—Pharyngitis—Epirubicin—bone cancer	0.000317	0.00211	CcSEcCtD
Propofol—Visual impairment—Epirubicin—bone cancer	0.000308	0.00205	CcSEcCtD
Propofol—Chills—Methotrexate—bone cancer	0.000307	0.00204	CcSEcCtD
Propofol—Diarrhoea—Cisplatin—bone cancer	0.000303	0.00201	CcSEcCtD
Propofol—Bradycardia—Doxorubicin—bone cancer	0.000301	0.002	CcSEcCtD
Propofol—Tinnitus—Epirubicin—bone cancer	0.000298	0.00198	CcSEcCtD
Propofol—Erythema—Methotrexate—bone cancer	0.000297	0.00198	CcSEcCtD
Propofol—Haemoglobin—Doxorubicin—bone cancer	0.000297	0.00197	CcSEcCtD
Propofol—Flushing—Epirubicin—bone cancer	0.000297	0.00197	CcSEcCtD
Propofol—Haemorrhage—Doxorubicin—bone cancer	0.000296	0.00196	CcSEcCtD
Propofol—Pharyngitis—Doxorubicin—bone cancer	0.000294	0.00195	CcSEcCtD
Propofol—Dysgeusia—Methotrexate—bone cancer	0.000291	0.00193	CcSEcCtD
Propofol—Chills—Epirubicin—bone cancer	0.000287	0.00191	CcSEcCtD
Propofol—Arrhythmia—Epirubicin—bone cancer	0.000286	0.0019	CcSEcCtD
Propofol—Visual impairment—Doxorubicin—bone cancer	0.000285	0.00189	CcSEcCtD
Propofol—Vomiting—Cisplatin—bone cancer	0.000281	0.00187	CcSEcCtD
Propofol—Rash—Cisplatin—bone cancer	0.000279	0.00185	CcSEcCtD
Propofol—Dermatitis—Cisplatin—bone cancer	0.000279	0.00185	CcSEcCtD
Propofol—Erythema—Epirubicin—bone cancer	0.000278	0.00185	CcSEcCtD
Propofol—Tinnitus—Doxorubicin—bone cancer	0.000276	0.00183	CcSEcCtD
Propofol—Flushing—Doxorubicin—bone cancer	0.000275	0.00182	CcSEcCtD
Propofol—Dysgeusia—Epirubicin—bone cancer	0.000273	0.00181	CcSEcCtD
Propofol—Muscle spasms—Epirubicin—bone cancer	0.000268	0.00178	CcSEcCtD
Propofol—Chills—Doxorubicin—bone cancer	0.000265	0.00176	CcSEcCtD
Propofol—Arrhythmia—Doxorubicin—bone cancer	0.000264	0.00176	CcSEcCtD
Propofol—Nausea—Cisplatin—bone cancer	0.000263	0.00175	CcSEcCtD
Propofol—Cough—Methotrexate—bone cancer	0.00026	0.00172	CcSEcCtD
Propofol—Convulsion—Methotrexate—bone cancer	0.000258	0.00171	CcSEcCtD
Propofol—Erythema—Doxorubicin—bone cancer	0.000258	0.00171	CcSEcCtD
Propofol—Agitation—Epirubicin—bone cancer	0.000256	0.0017	CcSEcCtD
Propofol—Chest pain—Methotrexate—bone cancer	0.000253	0.00168	CcSEcCtD
Propofol—Myalgia—Methotrexate—bone cancer	0.000253	0.00168	CcSEcCtD
Propofol—Dysgeusia—Doxorubicin—bone cancer	0.000252	0.00168	CcSEcCtD
Propofol—Syncope—Epirubicin—bone cancer	0.00025	0.00166	CcSEcCtD
Propofol—Muscle spasms—Doxorubicin—bone cancer	0.000248	0.00164	CcSEcCtD
Propofol—Confusional state—Methotrexate—bone cancer	0.000245	0.00163	CcSEcCtD
Propofol—Loss of consciousness—Epirubicin—bone cancer	0.000245	0.00162	CcSEcCtD
Propofol—Cough—Epirubicin—bone cancer	0.000243	0.00161	CcSEcCtD
Propofol—Anaphylactic shock—Methotrexate—bone cancer	0.000243	0.00161	CcSEcCtD
Propofol—Convulsion—Epirubicin—bone cancer	0.000241	0.0016	CcSEcCtD
Propofol—Hypertension—Epirubicin—bone cancer	0.00024	0.0016	CcSEcCtD
Propofol—Myalgia—Epirubicin—bone cancer	0.000237	0.00157	CcSEcCtD
Propofol—Chest pain—Epirubicin—bone cancer	0.000237	0.00157	CcSEcCtD
Propofol—Agitation—Doxorubicin—bone cancer	0.000237	0.00157	CcSEcCtD
Propofol—Anxiety—Epirubicin—bone cancer	0.000236	0.00157	CcSEcCtD
Propofol—Hyperhidrosis—Methotrexate—bone cancer	0.000235	0.00156	CcSEcCtD
Propofol—Dry mouth—Epirubicin—bone cancer	0.000232	0.00154	CcSEcCtD
Propofol—Syncope—Doxorubicin—bone cancer	0.000231	0.00153	CcSEcCtD
Propofol—Confusional state—Epirubicin—bone cancer	0.000229	0.00152	CcSEcCtD
Propofol—Anaphylactic shock—Epirubicin—bone cancer	0.000227	0.00151	CcSEcCtD
Propofol—Oedema—Epirubicin—bone cancer	0.000227	0.00151	CcSEcCtD
Propofol—Hypotension—Methotrexate—bone cancer	0.000227	0.00151	CcSEcCtD
Propofol—Loss of consciousness—Doxorubicin—bone cancer	0.000226	0.0015	CcSEcCtD
Propofol—Cough—Doxorubicin—bone cancer	0.000225	0.00149	CcSEcCtD
Propofol—Shock—Epirubicin—bone cancer	0.000223	0.00148	CcSEcCtD
Propofol—Convulsion—Doxorubicin—bone cancer	0.000223	0.00148	CcSEcCtD
Propofol—Hypertension—Doxorubicin—bone cancer	0.000222	0.00148	CcSEcCtD
Propofol—Tachycardia—Epirubicin—bone cancer	0.000222	0.00147	CcSEcCtD
Propofol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000221	0.00147	CcSEcCtD
Propofol—Hyperhidrosis—Epirubicin—bone cancer	0.00022	0.00146	CcSEcCtD
Propofol—Insomnia—Methotrexate—bone cancer	0.00022	0.00146	CcSEcCtD
Propofol—Chest pain—Doxorubicin—bone cancer	0.000219	0.00146	CcSEcCtD
Propofol—Myalgia—Doxorubicin—bone cancer	0.000219	0.00146	CcSEcCtD
Propofol—Anxiety—Doxorubicin—bone cancer	0.000218	0.00145	CcSEcCtD
Propofol—Paraesthesia—Methotrexate—bone cancer	0.000218	0.00145	CcSEcCtD
Propofol—Dyspnoea—Methotrexate—bone cancer	0.000216	0.00144	CcSEcCtD
Propofol—Somnolence—Methotrexate—bone cancer	0.000216	0.00143	CcSEcCtD
Propofol—Dry mouth—Doxorubicin—bone cancer	0.000214	0.00142	CcSEcCtD
Propofol—Hypotension—Epirubicin—bone cancer	0.000212	0.00141	CcSEcCtD
Propofol—Confusional state—Doxorubicin—bone cancer	0.000212	0.00141	CcSEcCtD
Propofol—Anaphylactic shock—Doxorubicin—bone cancer	0.00021	0.0014	CcSEcCtD
Propofol—Oedema—Doxorubicin—bone cancer	0.00021	0.0014	CcSEcCtD
Propofol—Fatigue—Methotrexate—bone cancer	0.000209	0.00139	CcSEcCtD
Propofol—Pain—Methotrexate—bone cancer	0.000208	0.00138	CcSEcCtD
Propofol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000207	0.00137	CcSEcCtD
Propofol—Shock—Doxorubicin—bone cancer	0.000207	0.00137	CcSEcCtD
Propofol—Insomnia—Epirubicin—bone cancer	0.000205	0.00136	CcSEcCtD
Propofol—Tachycardia—Doxorubicin—bone cancer	0.000205	0.00136	CcSEcCtD
Propofol—Paraesthesia—Epirubicin—bone cancer	0.000204	0.00135	CcSEcCtD
Propofol—Hyperhidrosis—Doxorubicin—bone cancer	0.000203	0.00135	CcSEcCtD
Propofol—Dyspnoea—Epirubicin—bone cancer	0.000203	0.00135	CcSEcCtD
Propofol—Somnolence—Epirubicin—bone cancer	0.000202	0.00134	CcSEcCtD
Propofol—Feeling abnormal—Methotrexate—bone cancer	0.0002	0.00133	CcSEcCtD
Propofol—Hypotension—Doxorubicin—bone cancer	0.000196	0.0013	CcSEcCtD
Propofol—Fatigue—Epirubicin—bone cancer	0.000196	0.0013	CcSEcCtD
Propofol—Pain—Epirubicin—bone cancer	0.000194	0.00129	CcSEcCtD
Propofol—Urticaria—Methotrexate—bone cancer	0.000193	0.00128	CcSEcCtD
Propofol—Abdominal pain—Methotrexate—bone cancer	0.000192	0.00127	CcSEcCtD
Propofol—Body temperature increased—Methotrexate—bone cancer	0.000192	0.00127	CcSEcCtD
Propofol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000191	0.00127	CcSEcCtD
Propofol—Insomnia—Doxorubicin—bone cancer	0.00019	0.00126	CcSEcCtD
Propofol—Paraesthesia—Doxorubicin—bone cancer	0.000189	0.00125	CcSEcCtD
Propofol—Dyspnoea—Doxorubicin—bone cancer	0.000187	0.00124	CcSEcCtD
Propofol—Feeling abnormal—Epirubicin—bone cancer	0.000187	0.00124	CcSEcCtD
Propofol—Somnolence—Doxorubicin—bone cancer	0.000187	0.00124	CcSEcCtD
Propofol—Fatigue—Doxorubicin—bone cancer	0.000181	0.0012	CcSEcCtD
Propofol—Urticaria—Epirubicin—bone cancer	0.00018	0.0012	CcSEcCtD
Propofol—Pain—Doxorubicin—bone cancer	0.00018	0.00119	CcSEcCtD
Propofol—Abdominal pain—Epirubicin—bone cancer	0.00018	0.00119	CcSEcCtD
Propofol—Body temperature increased—Epirubicin—bone cancer	0.00018	0.00119	CcSEcCtD
Propofol—Asthenia—Methotrexate—bone cancer	0.000174	0.00116	CcSEcCtD
Propofol—Feeling abnormal—Doxorubicin—bone cancer	0.000173	0.00115	CcSEcCtD
Propofol—Pruritus—Methotrexate—bone cancer	0.000172	0.00114	CcSEcCtD
Propofol—Urticaria—Doxorubicin—bone cancer	0.000167	0.00111	CcSEcCtD
Propofol—Abdominal pain—Doxorubicin—bone cancer	0.000166	0.0011	CcSEcCtD
Propofol—Body temperature increased—Doxorubicin—bone cancer	0.000166	0.0011	CcSEcCtD
Propofol—Diarrhoea—Methotrexate—bone cancer	0.000166	0.0011	CcSEcCtD
Propofol—Asthenia—Epirubicin—bone cancer	0.000163	0.00108	CcSEcCtD
Propofol—Pruritus—Epirubicin—bone cancer	0.000161	0.00107	CcSEcCtD
Propofol—Dizziness—Methotrexate—bone cancer	0.000161	0.00107	CcSEcCtD
Propofol—Diarrhoea—Epirubicin—bone cancer	0.000155	0.00103	CcSEcCtD
Propofol—Vomiting—Methotrexate—bone cancer	0.000154	0.00103	CcSEcCtD
Propofol—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000153	0.000967	CbGpPWpGaD
Propofol—Rash—Methotrexate—bone cancer	0.000153	0.00102	CcSEcCtD
Propofol—Dermatitis—Methotrexate—bone cancer	0.000153	0.00102	CcSEcCtD
Propofol—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000152	0.000963	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000152	0.000962	CbGpPWpGaD
Propofol—Headache—Methotrexate—bone cancer	0.000152	0.00101	CcSEcCtD
Propofol—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000151	0.000955	CbGpPWpGaD
Propofol—Asthenia—Doxorubicin—bone cancer	0.000151	0.001	CcSEcCtD
Propofol—Dizziness—Epirubicin—bone cancer	0.00015	0.000998	CcSEcCtD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00015	0.000945	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—ENO2—bone cancer	0.000149	0.000939	CbGpPWpGaD
Propofol—Pruritus—Doxorubicin—bone cancer	0.000149	0.000988	CcSEcCtD
Propofol—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000146	0.000921	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000146	0.00092	CbGpPWpGaD
Propofol—Vomiting—Epirubicin—bone cancer	0.000144	0.000959	CcSEcCtD
Propofol—Nausea—Methotrexate—bone cancer	0.000144	0.000958	CcSEcCtD
Propofol—Diarrhoea—Doxorubicin—bone cancer	0.000144	0.000955	CcSEcCtD
Propofol—Rash—Epirubicin—bone cancer	0.000143	0.000951	CcSEcCtD
Propofol—Dermatitis—Epirubicin—bone cancer	0.000143	0.00095	CcSEcCtD
Propofol—Headache—Epirubicin—bone cancer	0.000142	0.000945	CcSEcCtD
Propofol—SCN4A—Axon guidance—MMP2—bone cancer	0.000141	0.000891	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—MMP2—bone cancer	0.000141	0.000891	CbGpPWpGaD
Propofol—Dizziness—Doxorubicin—bone cancer	0.000139	0.000923	CcSEcCtD
Propofol—CYP2C18—Metabolism—NT5C3A—bone cancer	0.000139	0.000877	CbGpPWpGaD
Propofol—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000139	0.000875	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—DHFR—bone cancer	0.000138	0.000871	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000138	0.000868	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000137	0.000866	CbGpPWpGaD
Propofol—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000136	0.000857	CbGpPWpGaD
Propofol—Nausea—Epirubicin—bone cancer	0.000135	0.000896	CcSEcCtD
Propofol—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000135	0.000851	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000134	0.000845	CbGpPWpGaD
Propofol—Vomiting—Doxorubicin—bone cancer	0.000134	0.000888	CcSEcCtD
Propofol—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000133	0.000839	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—NDUFA12—bone cancer	0.000133	0.000837	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—NDUFA12—bone cancer	0.000133	0.000837	CbGpPWpGaD
Propofol—Rash—Doxorubicin—bone cancer	0.000133	0.00088	CcSEcCtD
Propofol—Dermatitis—Doxorubicin—bone cancer	0.000132	0.000879	CcSEcCtD
Propofol—Headache—Doxorubicin—bone cancer	0.000132	0.000875	CcSEcCtD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000131	0.000826	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—GNA11—bone cancer	0.000129	0.000814	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000129	0.000812	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000128	0.000806	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000127	0.000802	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000125	0.000792	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000125	0.000792	CbGpPWpGaD
Propofol—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000125	0.000791	CbGpPWpGaD
Propofol—Nausea—Doxorubicin—bone cancer	0.000125	0.000829	CcSEcCtD
Propofol—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000124	0.000781	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—NDUFA12—bone cancer	0.000124	0.000781	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000123	0.000777	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—CDK4—bone cancer	0.000121	0.000762	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—CDK4—bone cancer	0.000121	0.000762	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—MET—bone cancer	0.000121	0.000762	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—MET—bone cancer	0.000121	0.000762	CbGpPWpGaD
Propofol—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000118	0.000748	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000118	0.000743	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—CYP3A4—bone cancer	0.000117	0.000738	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000116	0.000735	CbGpPWpGaD
Propofol—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000116	0.000733	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000115	0.000728	CbGpPWpGaD
Propofol—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000115	0.000727	CbGpPWpGaD
Propofol—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000115	0.000725	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000115	0.000723	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000115	0.000723	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000115	0.000723	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000114	0.000721	CbGpPWpGaD
Propofol—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000114	0.000717	CbGpPWpGaD
Propofol—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000113	0.000712	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000113	0.00071	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—NT5C3A—bone cancer	0.00011	0.000693	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—NT5C3A—bone cancer	0.00011	0.000693	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00011	0.000692	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.000109	0.000686	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—JUN—bone cancer	0.000109	0.000685	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—ENO2—bone cancer	0.000108	0.000685	CbGpPWpGaD
Propofol—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000107	0.000676	CbGpPWpGaD
Propofol—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000107	0.000675	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—MMP9—bone cancer	0.000106	0.00067	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—MMP9—bone cancer	0.000106	0.00067	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000105	0.00066	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000104	0.000656	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000103	0.000651	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000103	0.000651	CbGpPWpGaD
Propofol—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000103	0.000647	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—NT5C3A—bone cancer	0.000102	0.000647	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000102	0.000645	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—MMP2—bone cancer	0.000101	0.000636	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—MMP2—bone cancer	0.000101	0.000636	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—DHFR—bone cancer	0.000101	0.000635	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—GSTP1—bone cancer	0.0001	0.000631	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—GSTP1—bone cancer	9.96e-05	0.000629	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	9.83e-05	0.000621	CbGpPWpGaD
Propofol—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	9.82e-05	0.00062	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	9.66e-05	0.00061	CbGpPWpGaD
Propofol—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	9.64e-05	0.000609	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—MDM2—bone cancer	9.6e-05	0.000606	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.56e-05	0.000604	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.48e-05	0.000598	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	9.47e-05	0.000598	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	9.43e-05	0.000595	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	9.43e-05	0.000595	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—BRAF—bone cancer	9.42e-05	0.000595	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—GNA11—bone cancer	9.41e-05	0.000594	CbGpPWpGaD
Propofol—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.35e-05	0.00059	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.29e-05	0.000587	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.89e-05	0.000561	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.88e-05	0.00056	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—BRAF—bone cancer	8.84e-05	0.000558	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—BRAF—bone cancer	8.78e-05	0.000554	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	8.77e-05	0.000554	CbGpPWpGaD
Propofol—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.77e-05	0.000554	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	8.74e-05	0.000552	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—BRAF—bone cancer	8.62e-05	0.000544	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—EGFR—bone cancer	8.57e-05	0.000541	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—EGFR—bone cancer	8.57e-05	0.000541	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CYP3A4—bone cancer	8.53e-05	0.000538	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—NT5C3A—bone cancer	8.47e-05	0.000535	CbGpPWpGaD
Propofol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.25e-05	0.000521	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—NDUFA12—bone cancer	8.24e-05	0.000521	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	8.24e-05	0.00052	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.18e-05	0.000516	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.11e-05	0.000512	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.1e-05	0.000511	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—NDUFA12—bone cancer	8.07e-05	0.00051	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.06e-05	0.000509	CbGpPWpGaD
Propofol—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.99e-05	0.000505	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	7.99e-05	0.000504	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—MDM2—bone cancer	7.9e-05	0.000499	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.66e-05	0.000484	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—NDUFA12—bone cancer	7.61e-05	0.000481	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—MMP9—bone cancer	7.57e-05	0.000478	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—MMP9—bone cancer	7.57e-05	0.000478	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—BRAF—bone cancer	7.53e-05	0.000476	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—MDM2—bone cancer	7.4e-05	0.000467	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—MDM2—bone cancer	7.35e-05	0.000464	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.31e-05	0.000461	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.31e-05	0.000461	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—GSTP1—bone cancer	7.29e-05	0.000461	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—MDM2—bone cancer	7.22e-05	0.000456	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—NDUFA12—bone cancer	6.98e-05	0.000441	CbGpPWpGaD
Propofol—ALB—Metabolism—NDUFA12—bone cancer	6.94e-05	0.000438	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—GSTP1—bone cancer	6.93e-05	0.000437	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—NT5C3A—bone cancer	6.83e-05	0.000431	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.83e-05	0.000431	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—NT5C3A—bone cancer	6.69e-05	0.000422	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TP53—bone cancer	6.57e-05	0.000415	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—MDM2—bone cancer	6.31e-05	0.000399	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—NT5C3A—bone cancer	6.31e-05	0.000398	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—NDUFA12—bone cancer	6.23e-05	0.000393	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EGFR—bone cancer	6.12e-05	0.000386	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EGFR—bone cancer	6.12e-05	0.000386	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—ENO2—bone cancer	6.09e-05	0.000384	CbGpPWpGaD
Propofol—ALB—Hemostasis—SPARC—bone cancer	5.89e-05	0.000372	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—NT5C3A—bone cancer	5.78e-05	0.000365	CbGpPWpGaD
Propofol—ALB—Metabolism—NT5C3A—bone cancer	5.75e-05	0.000363	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—NDUFA12—bone cancer	5.73e-05	0.000362	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—NDUFA12—bone cancer	5.68e-05	0.000359	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—DHFR—bone cancer	5.65e-05	0.000357	CbGpPWpGaD
Propofol—ALB—Hemostasis—GNA11—bone cancer	5.39e-05	0.00034	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.35e-05	0.000338	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GNA11—bone cancer	5.28e-05	0.000333	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.27e-05	0.000333	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PTGS2—bone cancer	5.18e-05	0.000327	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—NT5C3A—bone cancer	5.16e-05	0.000326	CbGpPWpGaD
Propofol—ALB—Hemostasis—IL3—bone cancer	4.88e-05	0.000308	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—NDUFA12—bone cancer	4.85e-05	0.000306	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ENO2—bone cancer	4.81e-05	0.000304	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ENO2—bone cancer	4.81e-05	0.000304	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CYP3A4—bone cancer	4.78e-05	0.000302	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—NT5C3A—bone cancer	4.75e-05	0.0003	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—NT5C3A—bone cancer	4.71e-05	0.000297	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ENO2—bone cancer	4.49e-05	0.000283	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—DHFR—bone cancer	4.46e-05	0.000282	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—DHFR—bone cancer	4.46e-05	0.000282	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GNA11—bone cancer	4.17e-05	0.000263	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GNA11—bone cancer	4.17e-05	0.000263	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—DHFR—bone cancer	4.16e-05	0.000263	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GSTP1—bone cancer	4.09e-05	0.000258	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—NT5C3A—bone cancer	4.02e-05	0.000254	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GNA11—bone cancer	3.89e-05	0.000246	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CYP3A4—bone cancer	3.78e-05	0.000239	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CYP3A4—bone cancer	3.78e-05	0.000239	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PTGS2—bone cancer	3.78e-05	0.000239	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.76e-05	0.000238	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NDUFA12—bone cancer	3.75e-05	0.000237	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ENO2—bone cancer	3.71e-05	0.000234	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP3A4—bone cancer	3.53e-05	0.000223	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.51e-05	0.000222	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—DHFR—bone cancer	3.44e-05	0.000217	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GSTP1—bone cancer	3.23e-05	0.000204	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GSTP1—bone cancer	3.23e-05	0.000204	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GNA11—bone cancer	3.22e-05	0.000203	CbGpPWpGaD
Propofol—ALB—Hemostasis—PLAU—bone cancer	3.2e-05	0.000202	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NT5C3A—bone cancer	3.1e-05	0.000196	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GSTP1—bone cancer	3.02e-05	0.00019	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ENO2—bone cancer	2.99e-05	0.000189	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ENO2—bone cancer	2.93e-05	0.000185	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP3A4—bone cancer	2.92e-05	0.000184	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—DHFR—bone cancer	2.78e-05	0.000175	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ENO2—bone cancer	2.76e-05	0.000174	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—DHFR—bone cancer	2.72e-05	0.000172	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GNA11—bone cancer	2.59e-05	0.000164	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—DHFR—bone cancer	2.56e-05	0.000162	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GNA11—bone cancer	2.54e-05	0.00016	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ENO2—bone cancer	2.53e-05	0.00016	CbGpPWpGaD
Propofol—ALB—Metabolism—ENO2—bone cancer	2.52e-05	0.000159	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSTP1—bone cancer	2.49e-05	0.000157	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GNA11—bone cancer	2.4e-05	0.000151	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP3A4—bone cancer	2.35e-05	0.000149	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—DHFR—bone cancer	2.35e-05	0.000148	CbGpPWpGaD
Propofol—ALB—Metabolism—DHFR—bone cancer	2.34e-05	0.000148	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP3A4—bone cancer	2.3e-05	0.000145	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ENO2—bone cancer	2.26e-05	0.000143	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GNA11—bone cancer	2.2e-05	0.000139	CbGpPWpGaD
Propofol—ALB—Metabolism—GNA11—bone cancer	2.18e-05	0.000138	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP3A4—bone cancer	2.17e-05	0.000137	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.16e-05	0.000136	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTGS2—bone cancer	2.12e-05	0.000134	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—DHFR—bone cancer	2.1e-05	0.000132	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ENO2—bone cancer	2.08e-05	0.000131	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ENO2—bone cancer	2.06e-05	0.00013	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTP1—bone cancer	2.01e-05	0.000127	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP3A4—bone cancer	1.99e-05	0.000126	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.98e-05	0.000125	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000125	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTP1—bone cancer	1.97e-05	0.000124	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.97e-05	0.000124	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GNA11—bone cancer	1.96e-05	0.000124	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—DHFR—bone cancer	1.93e-05	0.000122	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—DHFR—bone cancer	1.91e-05	0.000121	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTP1—bone cancer	1.86e-05	0.000117	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GNA11—bone cancer	1.8e-05	0.000114	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GNA11—bone cancer	1.79e-05	0.000113	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP3A4—bone cancer	1.78e-05	0.000112	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.77e-05	0.000112	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ENO2—bone cancer	1.76e-05	0.000111	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTP1—bone cancer	1.7e-05	0.000108	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTP1—bone cancer	1.69e-05	0.000107	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—bone cancer	1.68e-05	0.000106	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—bone cancer	1.68e-05	0.000106	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000103	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—DHFR—bone cancer	1.63e-05	0.000103	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP3A4—bone cancer	1.62e-05	0.000102	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.61e-05	0.000102	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—bone cancer	1.56e-05	9.87e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GNA11—bone cancer	1.53e-05	9.65e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTP1—bone cancer	1.52e-05	9.6e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTP1—bone cancer	1.4e-05	8.83e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTP1—bone cancer	1.39e-05	8.75e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP3A4—bone cancer	1.38e-05	8.74e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.38e-05	8.7e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ENO2—bone cancer	1.36e-05	8.59e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—bone cancer	1.29e-05	8.16e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—bone cancer	1.29e-05	8.13e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—DHFR—bone cancer	1.26e-05	7.96e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTP1—bone cancer	1.18e-05	7.48e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GNA11—bone cancer	1.18e-05	7.44e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—bone cancer	1.04e-05	6.58e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—bone cancer	1.02e-05	6.45e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—bone cancer	9.62e-06	6.08e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTP1—bone cancer	9.14e-06	5.77e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—bone cancer	8.82e-06	5.57e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—bone cancer	8.77e-06	5.54e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—bone cancer	7.88e-06	4.97e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—bone cancer	7.24e-06	4.57e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—bone cancer	7.18e-06	4.53e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—bone cancer	6.14e-06	3.87e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—bone cancer	4.74e-06	2.99e-05	CbGpPWpGaD
